Tag Archives: Merck
New Delhi: Not even a single Indian pharmaceutical company features in the list of world’s top 20 companies that have attempted at making medicines affordable for those in low and middle income countries, revealed a recent study by the Netherlands-based Access to Medicine Foundation.
Progress and technological advancement in the field of medical science have created several opportunities in the field of oncology and oncology drugs.
New drug combination may improve outcomes for women with advanced breast cancer when administered before surgery
New Orleans (US): Results from the I-SPY 2 trial show that giving patients with HER2-positive invasive breast cancer a combination of the drugs trastuzumab emtansine (T-DM1) and pertuzumab before surgery was more beneficial than the combination of paclitaxel plus trastuzumab.
With 10 percent of 3.63 trillion medicines popped worldwide in 2015, India is the world’s third-largest medicine market. It stands to scientific reason that these drugs will have side effects.
Washington: The US Food and Drug Administration on Monday approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults.
Mumbai: Maharashtra Governor C V Rao on Saturday asked the Indian pharmaceutical industry to develop drugs for lifestyle diseases like diabetes, hypertension, cardiovascular ailments and tuberculosis, among others.
Washington: The US Food and Drug Administration has approved Opdivo (nivolumab) to treat patients with advanced (metastatic) non-small cell lung cancer whose disease progressed during or after platinum-based chemotherapy.
New Delhi: The Delhi High Court on Wednesday restrained Mumbai-based Glenmark Pharmaceuticals Ltd from making or selling its generic anti-diabetes drugs Zita and Zita-Met while holding it infringing patent of a US drug maker Merck, Sharp and Dohme Corporation.
Washington: The US Food and Drug Administration on Friday granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumours that express a protein called PD-L1.
New York (IANS): Total global spending on cancer medicines — including therapeutic treatments and supportive care — have reached the $100-billion threshold in 2014, says a report.